课题基金 / 基金详情

项目摘要

项目成果

Li Wu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The HIV-1 pathogenic factor Nef and its interactions with host proteins are important for viral pathogenesis, but their role in HIV-1 latency is not known. Nef-associated factor 1 (Naf1), also known as A20-binding inhibitor of NF-kB (ABIN1), is a host protein that inhibits NF-kB activation. NF-kB is a well-known regulator HIV-1 gene expression and viral latency. Intriguingly, our preliminary studies suggest that Naf1 and Nef interplay regulates HIV-1 gene transcription and viral latency. We found that (1) Naf1 suppresses NF-kB- dependent HIV-1 gene expression and Nef counteracts the effects; and (2) Naf1 maintains HIV-1 latency by suppressing viral gene transcription, while Nef antagonizes the effects. Therefore, we propose to delineate the mechanisms of Nef-Naf1 interactions in regulating HIV-1 latency and to seek a new approach to overcome viral latency. Our central hypotheses are (1) Naf1 maintains HIV-1 latency by suppressing NF- kB-dependent viral gene transcription; (2) Nef antagonizes the inhibitory effects of Naf1 by inducing Naf1 phosphorylation, which activates PI3K/Akt signaling and leads to HIV-1 reactivation from latency. We propose two specific aims to test these novel hypotheses. Aim 1. To investigate the mechanisms by which the Naf1-Nef interaction regulates HIV-1 gene expression. Aim 2. To determine the function of Naf1 and Nef interactions in modulating HIV-1 latency in primary CD4+ T cells. Accomplishing the proposed studies through our collaborative efforts will provide novel insights into the viral and cellular mechanisms of modulating HIV-1 latency. Our expected results will provide a basis to target Nef-Naf1 interactions and to enhance anti-retroviral therapy toward a functional cure for HIV-1/AIDS.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
金黄色葡萄球菌 Cas9 对 CXCR4 进行基因组修饰,使细胞对 HIV-1 感染具有抵抗力
DOI: 10.1186/s12977-017-0375-0
发表时间: 2017-11-15
期刊: Retrovirology
影响因子: 3.3
作者: [Wang Q, Chen S, Xiao Q, Liu Z, Liu S, Hou P, Zhou L, Hou W, Ho W, Li C, Wu L, Guo D]
通讯作者: Guo D
DOI: 10.3389/fimmu.2017.01541
发表时间: 2017
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Antonucci JM, St Gelais C, Wu L]
通讯作者: Wu L
DOI: 10.1016/j.tim.2018.09.009
发表时间: 2019-03
期刊: Trends in microbiology
影响因子: 15.9
作者: [Chen S, Bonifati S, Qin Z, St Gelais C, Wu L]
通讯作者: Wu L
Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development
  • 批准号:
    10596144
  • 项目类别:
  • 资助金额:
    $69.99万
  • 财政年份:
    2022
  • 负责人:
    Li Wu
  • 依托单位:
Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development
  • 批准号:
    10462273
  • 项目类别:
  • 资助金额:
    $75.13万
  • 财政年份:
    2022
  • 负责人:
    Li Wu
  • 依托单位:
Epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells
  • 批准号:
    10412132
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2021
  • 负责人:
    Li Wu
  • 依托单位:
Epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells
  • 批准号:
    10297640
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2021
  • 负责人:
    Li Wu
  • 依托单位:
海外基金